Infection with multidrug‐resistant gram‐negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes

Rosolem, 2012, Critically ill patients with cancer and sepsis: clinical course and prognostic factors, J Crit Care, 27, 301, 10.1016/j.jcrc.2011.06.014 Turkoglu, 2011, Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality, J Crit Care, 26, 460, 10.1016/j.jcrc.2011.04.007 Montassier, 2013, Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance, Eur J Clin Microbiol Infect Dis, 32, 841, 10.1007/s10096-013-1819-7 Gudiol, 2011, Bacteraemia due to multidrug‐resistant Gram‐negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes, J Antimicrob Chemother, 66, 657, 10.1093/jac/dkq494 Volles, 2008, Antibiotics in the intensive care unit: focus on agents for resistant pathogens, Emerg Med Clin North Am, 26, 813, 10.1016/j.emc.2008.04.006 Vardakas, 2013, Predictors of mortality in patients with infections due to multi‐drug resistant Gram negative bacteria: the study, the patient, the bug or the drug, J Infect, 66, 401, 10.1016/j.jinf.2012.10.028 El-Mahallawy, 2011, Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer, Pediatr Blood Cancer, 57, 283, 10.1002/pbc.22926 Borer, 2012, Risk factors for developing clinical infection with carbapenem‐resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem‐resistant K. pneumoniae, Am J Infect Control, 40, 421, 10.1016/j.ajic.2011.05.022 Blot, 2005, Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic‐resistant gram‐negative bacteria in an intensive care unit, Infect Control Hosp Epidemiol, 26, 575, 10.1086/502575 Ashour, 2009, Species distribution and antimicrobial susceptibility of gram‐negative aerobic bacteria in hospitalized cancer patients, J Transl Med, 7, 14, 10.1186/1479-5876-7-14 Tantaleán, 2003, Multiple organ dysfunction syndrome in children, Pediatr Crit Care Med, 4, 181, 10.1097/01.PCC.0000059421.13161.88 Ariffin, 2000, Ceftazidime‐resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia, Int J Infect Dis, 4, 21, 10.1016/S1201-9712(00)90061-4 Fernandes, 2010, Molecular characterization of carbapenem‐resistant and metallo‐beta‐lactamase‐producing Pseudomonas aeruginosa isolated from blood cultures from children and teenagers with cancer, Rev Soc Bras Med Trop, 43, 372, 10.1590/S0037-86822010000400007 Caselli, 2010, Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoieticstem cell transplantation, Haematologica, 95, 1612, 10.3324/haematol.2009.020867 Grisaru-Soen, 2007, Nosocomial bloodstream infections in a pediatric intensive care unit: 3‐year survey, Med Sci Monit, 13, CR251 Mitt, 2014, Five‐year prospective surveillance of nosocomial bloodstream infections in an Estonian paediatric intensive care unit, J Hosp Infect, 86, 95, 10.1016/j.jhin.2013.11.002 Katragkou, 2006, Acquisition of imipenem‐resistant Acinetobacter baumannii in a pediatric intensive care unit: a case‐control study, Intensive Care Med, 32, 1384, 10.1007/s00134-006-0239-x Raymond, 2000, Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group, Infect Control Hosp Epidemiol, 21, 260, 10.1086/501755 Abramczyk, 2003, Nosocomial infection in a pediatric intensive care unit in a developing country, Braz J Infect Dis, 7, 375, 10.1590/S1413-86702003000600004 Ansari, 2007, Risk factors for infections with multidrug‐resistant Stenotrophomonas maltophilia in patients with cancer, Cancer, 109, 2615, 10.1002/cncr.22705 Haeusler, 2013, Antibiotic‐resistant Gram‐negative bacteremia in pediatric oncology patients – risk factors and outcomes, Pediatr Infect Dis J, 32, 723, 10.1097/INF.0b013e31828aebc8 Tabah, 2012, Characteristics and determinants of outcome of hospital‐acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study, Intensive Care Med, 38, 1930, 10.1007/s00134-012-2695-9 To, 2013, Clinical outcome of extended‐spectrum beta‐lactamase‐producing Escherichia coli bacteremia in an area with high endemicity, Int J Infect Dis, 17, e120, 10.1016/j.ijid.2012.09.008 Anderson, 2006, Predictors of mortality in patients with bloodstream infection due to ceftazidime‐resistant Klebsiella pneumoniae, Antimicrob Agents Chemother, 50, 1715, 10.1128/AAC.50.5.1715-1720.2006 Kang, 2004, Risk factors for and clinical outcomes of bloodstream infections caused by extended‐spectrum beta‐lactamase‐producing Klebsiella pneumoniae, Infect Control Hosp Epidemiol, 25, 860, 10.1086/502310 Gudiol, 2010, Bacteraemia due to extended‐spectrum beta‐lactamase‐producing Escherichia coli (ESBL‐EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome, J Antimicrob Chemother, 65, 333, 10.1093/jac/dkp411